These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21165705)

  • 41. Mechanism of dissociation of cortisol and adrenal androgen secretion after removal of adrenocortical adenoma in patients with Cushing's syndrome.
    Nawata H; Higuchi K; Yanase T; Takayanagi R; Kato K; Ibayashi H
    Endocrinol Jpn; 1985 Oct; 32(5):691-700. PubMed ID: 2936600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Sep; 22(9):1146-50. PubMed ID: 16108840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic value of standard deviation score of log-transformed serum dehydroepiandrosterone sulfate in patients with hypothalamic-pituitary-adrenal axis insufficiency.
    Edo N; Morita K; Ishiwata C; Nakajima R; Sayama Y; Suzuki T; Sakamoto M; Okamoto K; Uchino T; Ozawa Y; Uno K; Uno K; Tsukamoto K; Ishikawa T
    Endocr J; 2021 Nov; 68(11):1337-1345. PubMed ID: 34162776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis.
    Courtney CH; McAllister AS; McCance DR; Bell PM; Hadden DR; Leslie H; Sheridan B; Atkinson AB
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):431-6. PubMed ID: 11012567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged hypothalamic-pituitary-adrenal axis activation after acute coronary syndrome in the GENESIS-PRAXY cohort.
    Tang AR; Rabi DM; Lavoie KL; Bacon SL; Pilote L; Kline GA
    Eur J Prev Cardiol; 2018 Jan; 25(1):65-72. PubMed ID: 28969495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
    Lytras N; Grossman A; Perry L; Tomlin S; Wass JA; Coy DH; Schally AV; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):71-84. PubMed ID: 6319053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the hypothalamic-pituitary-adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls.
    Demir H; Tanriverdi F; Ozoğul N; Caliş M; Kirnap M; Durak AC; Keleştimur F
    Scand J Rheumatol; 2006; 35(3):217-23. PubMed ID: 16766369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
    Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is there a gender difference in the associations of birthweight and adult hypothalamic-pituitary-adrenal axis activity?
    Reynolds RM; Walker BR; Syddall HE; Andrew R; Wood PJ; Phillips DI
    Eur J Endocrinol; 2005 Feb; 152(2):249-53. PubMed ID: 15745933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic changes in serum steroids for diagnosing and subtyping Cushing's syndrome.
    Ahn CH; Lee C; Shim J; Kong SH; Kim SJ; Kim YH; Lee KE; Shin CS; Kim JH; Choi MH
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105856. PubMed ID: 33647522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
    Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.
    Yener S; Demir L; Demirpence M; Mahmut Baris M; Simsir IY; Ozisik S; Comlekci A; Demir T
    Endocrine; 2017 May; 56(2):308-316. PubMed ID: 28247312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
    Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
    Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subclinical Cushing's syndrome.
    Terzolo M; Reimondo G; Bovio S; Angeli A
    Pituitary; 2004; 7(4):217-23. PubMed ID: 16132200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
    Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
    J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids.
    Duclos M; Gatta B; Corcuff JB; Rashedi M; Pehourcq F; Roger P
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):447-54. PubMed ID: 11678826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndrome.
    Doherty GM; Nieman LK; Cutler GB; Chrousos GP; Norton JA
    Surgery; 1990 Dec; 108(6):1085-90. PubMed ID: 2247834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke.
    Rosmond R; Björntorp P
    J Intern Med; 2000 Feb; 247(2):188-97. PubMed ID: 10692081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.